- £322.29m
- £86.26m
- $4.83m
REG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementREG - PureTech Health PLC - PRTC's Seaport Files for Proposed Nasdaq IPO
AnnouncementRCS - PureTech Health PLC - PRTC Publishes Phase 2b Deupirfenidone IPF Results
AnnouncementRCS - PureTech Health PLC - PRTC's Seaport: Positive Topline Ph1 for GlyphAgo
AnnouncementREG - PureTech Health PLC - Total Voting Rights
AnnouncementRCS - PureTech Health PLC - PRTC’s Seaport: GlyphAllo Paper Published
AnnouncementREG - PureTech Health PLC - PDMR Notification RSU Vesting
AnnouncementREG - PureTech Health PLC - Total Voting Rights
AnnouncementRCS - PureTech Health PLC - PRTC to Present at Leerink Healthcare Conference
AnnouncementRCS - PureTech Health PLC - PRTC's Deupirfenidone Granted FDA & EU ODD for IPF
AnnouncementRCS - PureTech Health PLC - PureTech to Present at the JP Morgan Conference
AnnouncementREG - PureTech Health PLC - PureTech Appoints Robert Lyne as CEO
AnnouncementREG - PureTech Health PLC - Results of AGM on June 16, 2025 – Update Statement
AnnouncementREG - PureTech Health PLC - Holding(s) in Company
AnnouncementRCS - PureTech Health PLC - PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
AnnouncementRCS - PureTech Health PLC - PRTC's Gallop: Positive Initial Topline AML Data
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
AnnouncementREG - PureTech Health PLC Citigroup Inc - Holding(s) in Company
Announcement